Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00805) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
YM-511
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Investigative Agent
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=177865"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Aromatase (CYP19A1) | DME Info | Homo sapiens | [1] | |||
| Xenobiotics-DME Activity Data | ||||||
| Xenobiotics-DME Activity Data | Aromatase (CYP19A1) | DME Info | IC50 = 0.00012 microM | [1] | ||
| References | ||||||
| 1 | Discovery and development of the aryl O-sulfamate pharmacophore for oncology and women's health. J Med Chem. 2015 Oct 8;58(19):7634-58. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.